DK1379671T3 - Fremgangsmåder til dyrkning af circovirus - Google Patents

Fremgangsmåder til dyrkning af circovirus

Info

Publication number
DK1379671T3
DK1379671T3 DK02712700T DK02712700T DK1379671T3 DK 1379671 T3 DK1379671 T3 DK 1379671T3 DK 02712700 T DK02712700 T DK 02712700T DK 02712700 T DK02712700 T DK 02712700T DK 1379671 T3 DK1379671 T3 DK 1379671T3
Authority
DK
Denmark
Prior art keywords
methods
culturing
circovirus
present
culturing circovirus
Prior art date
Application number
DK02712700T
Other languages
Danish (da)
English (en)
Inventor
Qiang Liu
Suresh K Tikoo
Philip Willson
Lorne A Babiuk
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Application granted granted Critical
Publication of DK1379671T3 publication Critical patent/DK1379671T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10051—Methods of production or purification of viral material
    • C12N2750/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK02712700T 2001-03-27 2002-03-27 Fremgangsmåder til dyrkning af circovirus DK1379671T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27917301P 2001-03-27 2001-03-27
PCT/CA2002/000413 WO2002077210A2 (fr) 2001-03-27 2002-03-27 Methodes de culture du circovirus

Publications (1)

Publication Number Publication Date
DK1379671T3 true DK1379671T3 (da) 2009-06-29

Family

ID=23067939

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02712700T DK1379671T3 (da) 2001-03-27 2002-03-27 Fremgangsmåder til dyrkning af circovirus

Country Status (24)

Country Link
US (3) US6794163B2 (fr)
EP (1) EP1379671B1 (fr)
JP (1) JP4038127B2 (fr)
KR (1) KR100876629B1 (fr)
CN (2) CN1840656B (fr)
AT (1) ATE430807T1 (fr)
AU (1) AU2002244584B2 (fr)
BR (1) BRPI0208456B8 (fr)
CA (1) CA2442135C (fr)
CY (1) CY1109267T1 (fr)
CZ (1) CZ304525B6 (fr)
DE (1) DE60232234D1 (fr)
DK (1) DK1379671T3 (fr)
ES (1) ES2324466T3 (fr)
HU (1) HU228065B1 (fr)
MX (1) MXPA03008810A (fr)
MY (2) MY148759A (fr)
PL (1) PL202951B1 (fr)
PT (1) PT1379671E (fr)
RU (2) RU2312142C2 (fr)
SK (1) SK287969B6 (fr)
UA (1) UA82647C2 (fr)
WO (1) WO2002077210A2 (fr)
ZA (1) ZA200307517B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040062775A1 (en) * 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
EP1379671B1 (fr) * 2001-03-27 2009-05-06 University of Saskatchewan Methodes de culture du circovirus
US20030096377A1 (en) * 2001-06-28 2003-05-22 Virginia Tech Intellectual Properties, Inc. Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
ES2814473T3 (es) 2005-12-29 2021-03-29 Boehringer Ingelheim Animal Health Usa Inc Composiciones inmunogénicas de PCV2 multivalentes y métodos para producir dichas composiciones
HUE029552T2 (en) 2005-12-29 2017-03-28 Boehringer Ingelheim Vetmedica Inc Use of PCV2 immunogenic composition to reduce clinical symptoms in piglets
EP2101815A4 (fr) 2006-12-11 2010-10-06 Boehringer Ingelheim Vetmed Procede efficace de traitement du circovirus porcin et des infections par lawsonia intracellularis
EP3466442A1 (fr) 2006-12-15 2019-04-10 Boehringer Ingelheim Vetmedica, Inc. Traitement des porcs mda positive avec l'antigène pcv2
EP1941903A1 (fr) * 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxie et traitement du PRDC
EP1958644A1 (fr) * 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prévention et traitement du PCVD subclinique
WO2008140414A1 (fr) * 2007-05-11 2008-11-20 Temasek Life Sciences Laboratory Limited Production d'une lignée de cellules homogènes hautement sensibles à une infection par le circovirus porcin de type 2 (pcv2)
WO2008151215A1 (fr) * 2007-06-04 2008-12-11 Merial Limited Production de protéines de circovirus porcin dans des plantes
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
JP2011507522A (ja) * 2007-12-21 2011-03-10 ワイス・エルエルシー 豚サーコウイルスに対してブタを免疫化するための方法および組成物
KR20100103535A (ko) * 2007-12-31 2010-09-27 베링거잉겔하임베트메디카인코퍼레이티드 외래 아미노산 삽입물을 갖는 ｐｃｖ２ ｏｒｆ２ 바이러스 유사 입자
MX2010007815A (es) 2008-01-23 2010-08-10 Boehringer Ingelheim Vetmed Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo.
AU2009236669B2 (en) * 2008-04-16 2012-12-06 Virginia Tech Intellectual Properties, Inc. Chimeric porcine circovirus PCV2Gen-1Rep and uses thereof
TWI627281B (zh) * 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
WO2011091389A2 (fr) * 2010-01-25 2011-07-28 Blood Systems, Inc. Cyclovirus et procédé d'utilisation
BR112016006192A2 (pt) 2013-09-25 2017-09-26 Zoetis Services Llc composição de vacina de divergente de pcv2b e métodos de uso
DK3052516T3 (da) 2013-10-02 2020-03-23 Boehringer Ingelheim Animal Health Usa Inc PCV2-ORF2-proteinvariant og viruslignende partikler sammensat deraf
US9944904B2 (en) 2015-05-14 2018-04-17 Merial Inc. Method for porcine circovirus production and PCV2 vaccines
WO2018071511A1 (fr) * 2016-10-11 2018-04-19 Orion Labs Transfert de communication de groupe vers un service secondaire
CN114934020B (zh) * 2022-01-30 2024-02-13 山东省滨州畜牧兽医研究院 猪视网膜上皮细胞系及其建立方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001507216A (ja) * 1996-10-23 2001-06-05 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 免疫療法および改良ワクチン
AUPO856097A0 (en) 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US7192594B2 (en) 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6517843B1 (en) * 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2781159B1 (fr) * 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US6287856B1 (en) 1998-03-13 2001-09-11 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
US6492343B1 (en) 1998-04-15 2002-12-10 University Of Saskatchewan Porcine adenovirus type 3 genome
ATE451378T1 (de) 1998-09-08 2009-12-15 Brij P Giri Chemolumineszente 1,2-dioxetane
WO2000026395A2 (fr) * 1998-11-02 2000-05-11 University Of Saskatchewan Cellules bovines exprimant les fonctions essentielles de l'adenovirus pour la propagation de vecteurs recombines de l'adenovirus
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
CA2413265A1 (fr) * 2000-05-03 2001-11-08 University Of Guelph Vaccin d'adenovirus porcin
EP1379671B1 (fr) 2001-03-27 2009-05-06 University of Saskatchewan Methodes de culture du circovirus

Also Published As

Publication number Publication date
CZ304525B6 (cs) 2014-06-18
UA82647C2 (uk) 2008-05-12
EP1379671B1 (fr) 2009-05-06
CA2442135C (fr) 2008-08-19
US7560278B2 (en) 2009-07-14
CN1840656A (zh) 2006-10-04
WO2002077210A2 (fr) 2002-10-03
BRPI0208456B1 (pt) 2016-10-18
MXPA03008810A (es) 2004-02-17
BR0208456A (pt) 2004-03-02
RU2312142C2 (ru) 2007-12-10
US20070128700A1 (en) 2007-06-07
CA2442135A1 (fr) 2002-10-03
MY146518A (en) 2012-08-15
PL202951B1 (pl) 2009-08-31
AU2002244584B2 (en) 2006-12-14
EP1379671A2 (fr) 2004-01-14
SK287969B6 (sk) 2012-08-06
BRPI0208456B8 (pt) 2021-05-25
CZ20032584A3 (en) 2004-03-17
JP4038127B2 (ja) 2008-01-23
CN1840656B (zh) 2010-06-02
RU2003131342A (ru) 2005-04-20
US20020177216A1 (en) 2002-11-28
PL364077A1 (en) 2004-12-13
MY148759A (en) 2013-05-31
HUP0500161A3 (en) 2010-01-28
DE60232234D1 (de) 2009-06-18
KR100876629B1 (ko) 2009-01-07
SK12102003A3 (sk) 2004-05-04
CN1625598A (zh) 2005-06-08
ES2324466T3 (es) 2009-08-07
US6794163B2 (en) 2004-09-21
ATE430807T1 (de) 2009-05-15
HU228065B1 (en) 2012-09-28
CN1309836C (zh) 2007-04-11
KR20040002881A (ko) 2004-01-07
US20050239187A1 (en) 2005-10-27
US7172899B2 (en) 2007-02-06
RU2007110808A (ru) 2008-09-27
PT1379671E (pt) 2009-07-20
ZA200307517B (en) 2004-09-27
CY1109267T1 (el) 2014-07-02
WO2002077210A3 (fr) 2003-08-21
JP2005500822A (ja) 2005-01-13
HUP0500161A2 (hu) 2005-05-30

Similar Documents

Publication Publication Date Title
DK1379671T3 (da) Fremgangsmåder til dyrkning af circovirus
DK1210411T3 (da) Sammensætninger og fremgangsmåder til forbedret celledyrkning
DK1749543T3 (da) Sammensætning til vævsregeneration
TW200611910A (en) Interferon-alpha polypeptides and conjugates
EP3486314A3 (fr) Populations de cellules souches placentaires
WO2006108183A3 (fr) Biocapteurs et cellules sans etiquette
DE60144145D1 (de) Subtilisin-variante
MY163480A (en) Sclerostin binding agents
MX2007012840A (es) Composiciones detergentes liquidas para lavanderia que tienen estabilidad y transparencia mejoradas.
AU2019268061A1 (en) Placental stem cell populations
HK1063334A1 (en) Compositions and methods useful for hcv infection
TW200716130A (en) Purified form of tanaproget
WO2004016743A3 (fr) Mise en culture de l'anaplasma
AU2003288621A1 (en) Rna bioassay
WO2002062970A8 (fr) Cellules precurseurs et souches derivees d'un systeme nerveux enterique et utilisations correspondantes
NO20040174L (no) Fremgangsmate for donorspesifikk krysstilpasning
ATE374243T1 (de) Knorpelzell-kulturmedium und verwendung desselben
GEP20074120B (en) Subcutaneously-administered ganglioside-based vaccine compositions